Lexology January 23, 2025
On January 20, 2025, President Donald Trump revoked Executive Order 14087, titled “Lowering Prescription Drug Costs for Americans,” which had promoted analyzing new healthcare payment models that would lower prescription costs for Medicare and Medicaid beneficiaries. 87 Fed Reg. 63399 (Oct. 19, 2022).
The repeal of the executive order will now lead to some uncertainty regarding costs for prescription drugs covered by Medicare, so pharmacists should expect questions about access to certain drugs and pricing, including rebates and reimbursement from pharmacy benefit managers (PBMs).
The Trump administration expressed interest in addressing prescription drug pricing, but the administration’s approach has not been announced.
Executive Order Complements the Inflation Reduction Act of 2022
The executive order was signed by President Joe Biden...
Today's Sponsors
Today's Sponsor